Correlation Between Puma Biotechnology and Amicus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Amicus Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Amicus Therapeutics.
Diversification Opportunities for Puma Biotechnology and Amicus Therapeutics
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Puma and Amicus is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Amicus Therapeutics go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Amicus Therapeutics
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.78 times more return on investment than Amicus Therapeutics. However, Puma Biotechnology is 1.78 times more volatile than Amicus Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Amicus Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 458.00 in Puma Biotechnology on August 29, 2024 and sell it today you would lose (144.00) from holding Puma Biotechnology or give up 31.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Amicus Therapeutics
Performance |
| Timeline |
| Puma Biotechnology |
| Amicus Therapeutics |
Puma Biotechnology and Amicus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Amicus Therapeutics
The main advantage of trading using opposite Puma Biotechnology and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |